OA08.02 Efficacy and Safety of 1L Olomorasib + Chemoimmunotherapy in KRAS G12C-Mutant NSCLC: Results From LOXO-RAS-20001 and SUNRAY-01

作者：M.V. Negrao, James Uyeki, I. Cicin, Yun Chen, B.Y. Shim, Masashi Yamaguchi, T.F. Burns, Garrett Sherwood, J. Nicholas Bodor, Jun Sakakibara‐Konishi, K. Dragnev, Natraj Reddy Ammakkanavar, Victor T. G. Lin, Sun Young Kim, Yunyun Zhou, N. Fasnacht, Aliza K. Fink, Μ. D. Willard, Carla Visseren‐Grul, Solange Peters · 发表于：Journal of Thoracic Oncology · 年份：2025 · DOI：10.1016/j.jtho.2025.09.055 · 被引用次数：4 · 研究领域：Cancer, Hypoxia, and Metabolism、Lung Cancer Treatments and Mutations、Colorectal Cancer Treatments and Studies